Semmelweis Publications
  • Main page

    • III. Department of Internal Medicine - Publications (2020-2025)

    Year:
    Order by:
    SU Authorship:
    Number of publications: 86
    1.
    EULAR definition of difficult-to-treat rheumatoid arthritis
    Nagy, G;Roodenrijs, NMT;Welsing, PMJ;Kedves, M;Hamar, A;van der Goes, MC;Kent, A;Bakkers, M;Blaas, E;Senolt, L;Szekanecz, Z;Choy, E;Dougados, M;Jacobs, JWG;Geenen, R;Bijlsma, HWJ;Zink, A;Aletaha, D;Schoneveld, L;van Riel, P;Gutermann, L;Prior, Y;Nikiphorou, E;Ferraccioli, G;Schett, G;Hyrich, KL;Mueller-Ladner, U;Buch, MH;McInnes, IB;van der Heijde, D;van Laar, JM
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2021.
    DOI:10.1136/annrheumdis-2020-217344 (Copy DOI)
    2.
    Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
    Sinkovits, G;Mezo, B;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Csuka, D;Hurler, L;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Valyi-Nagy, I;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.663187 (Copy DOI)
    3.
    Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
    Kiladjian, JJ;Zachee, P;Hino, M;Pane, F;Masszi, T;Harrison, CN;Mesa, R;Miller, CB;Passamonti, F;Durrant, S;Griesshammer, M;Kirito, K;Besses, C;Moiraghi, EB;Rumi, E;Rosti, V;Blau, IW;Francillard, N;Dong, T;Wroclawska, M;Vannucchi, AM;Verstovsek, S
    D1
    LANCET HAEMATOLOGY
    2020.
    DOI:10.1016/S2352-3026(19)30207-8 (Copy DOI)
    4.
    Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3
    Beelen, DW;Trenschel, R;Stelljes, M;Groth, C;Masszi, T;Reményi, P;Wagner-Drouet, EM;Hauptrock, B;Dreger, P;Luft, T;Bethge, W;Vogel, W;Ciceri, F;Peccatori, J;Stölzel, F;Schetelig, J;Junghanss, C;Grosse-Thie, C;Michallet, M;Labussiere-Wallet, H;Schaefer-Eckart, K;Dressler, S;Grigoleit, GU;Mielke, S;Scheid, C;Holtick, U;Patriarca, F;Medeot, M;Rambaldi, A;Micò, MC;Niederwieser, D;Franke, GN;Hilgendorf, I;Winkelmann, NR;Russo, D;Socié, G;de Latour, RP;Holler, E;Wolff, D;Glass, B;Casper, J;Wulf, G...
    D1
    LANCET HAEMATOLOGY
    2020.
    DOI:10.1016/S2352-3026(19)30157-7 (Copy DOI)
    5.
    Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group
    Mohty, M;Malard, F;Abecasis, M;Aerts, E;Alaskar, AS;Aljurf, M;Arat, M;Bader, P;Baron, F;Basak, G;Bazarbachi, A;Blaise, D;Ciceri, F;Corbacioglu, S;Dalle, JH;Dignan, F;Fukuda, T;Huynh, A;Kuball, J;Lachance, S;Lazarus, H;Masszi, T;Michallet, M;Nagler, A;NiChonghaile, M;Okamoto, S;Pagliuca, A;Peters, C;Petersen, FB;Richardson, PG;Ruutu, T;Saber, W;Savani, BN;Soiffer, R;Styczynski, J;Wallhult, E;Yakoub-Agha, I;Duarte, RF;Carreras, E
    Q1
    BONE MARROW TRANSPLANTATION
    2020.
    DOI:10.1038/s41409-019-0705-z (Copy DOI)
    6.
    Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    Richardson, PG;Kumar, SK;Masszi, T;Grzasko, N;Bahlis, NJ;Hansson, M;Pour, L;Sandhu, I;Ganly, P;Baker, BW;Jackson, SR;Stoppa, AM;Gimsing, P;Garderet, L;Touzeau, C;Buadi, FK;Laubach, JP;Cavo, M;Darif, M;Labotka, R;Berg, D;Moreau, P
    D1
    JOURNAL OF CLINICAL ONCOLOGY
    2021.
    DOI:10.1200/JCO.21.00972 (Copy DOI)
    7.
    Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus
    Kedves, M;Kósa, F;Kunovszki, P;Takács, P;Szabó, MZ;Karyekar, C;Lofland, JH;Nagy, G
    D1
    RHEUMATOLOGY
    2020.
    DOI:10.1093/rheumatology/keaa188 (Copy DOI)
    8.
    Neutrophils produce proinflammatory or anti-inflammatory extracellular vesicles depending on the environmental conditions
    Kolonics, F;Kajdácsi, E;Farkas, VJ;Veres, DS;Khamari, D;Kittel, A;Merchant, ML;McLeish, KR;Lorincz, AM;Ligeti, E
    Q1
    JOURNAL OF LEUKOCYTE BIOLOGY
    2021.
    DOI:10.1002/JLB.3A0320-210R (Copy DOI)
    9.
    Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
    Roose, E;Tellier, AS;Tellier, E;Sinkovits, G;Joly, BS;Dekimpe, C;Kaplanski, G;Le Besnerais, M;Mancini, I;Falter, T;Von Auer, C;Feys, HB;Reti, M;Rossmann, H;Vandenbulcke, A;Pareyn, I;Voorberg, J;Greinacher, A;Benhamou, Y;Deckmyn, H;Fijnheer, R;Prohaszka, Z;Peyvandi, F;Lämmle, B;Coppo, P;De Meyer, SF;Veyradier, A;Vanhoorelbeke, K
    D1
    BLOOD
    2020.
    DOI:10.1182/blood.2019004221 (Copy DOI)
    10.
    Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura
    Tarasco, E;Bütikofer, L;Friedman, KD;George, JN;Hrachovinova, I;Knöbl, PN;Matsumoto, M;von Krogh, AS;Aebi-Huber, I;Cermakova, Z;Górska-Kosicka, M;Jalowiec, KA;Largiadèr, CR;Prohászka, Z;Sinkovits, G;Windyga, J;Lämmle, B;Hovinga, JAK
    D1
    BLOOD
    2021.
    DOI:10.1182/blood.2020009801 (Copy DOI)
    11.
    Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib
    Gangó, A;Alpár, D;Galik, B;Marosvári, D;Kiss, R;Fesüs, V;Aczel, D;Eyupoglu, E;Nagy, N;Nagy, A;Krizsán, S;Reiniger, L;Farkas, P;Kozma, A;Adám, E;Tasnady, S;Reti, M;Matolcsy, A;Gyenesei, A;Matrai, Z;Bödör, C
    Q1
    INTERNATIONAL JOURNAL OF CANCER
    2020.
    DOI:10.1002/ijc.32502 (Copy DOI)
    12.
    Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
    Lumry, WR;Zuraw, B;Cicardi, M;Craig, T;Anderson, J;Banerji, A;Bernstein, JA;Caballero, T;Farkas, H;Gower, RG;Keith, PK;Levy, DS;Li, HH;Magerl, M;Manning, M;Riedl, MA;Lawo, JP;Prusty, S;Machnig, T;Longhurst, H
    Q1
    ORPHANET JOURNAL OF RARE DISEASES
    2021.
    DOI:10.1186/s13023-020-01658-4 (Copy DOI)
    13.
    Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
    Sinkovits, G;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhecz, Z;Mezo, B;Csuka, D;Hurler, L;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Vályi-Nagy, I;Prohászka, Z
    Q1
    THROMBOSIS AND HAEMOSTASIS
    2022.
    DOI:10.1055/s-0041-1740182 (Copy DOI)
    14.
    Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
    Kluin-Nelemans, HC;Reiter, A;Illerhaus, A;van Anrooij, B;Hartmann, K;Span, LFR;Gorska, A;Niedoszytko, M;Lange, M;Scaffidi, L;Zanotti, R;Bonadonna, P;Perkins, C;Elena, C;Malcovati, L;Shoumariyeh, K;von Bubnoff, N;Parente, R;Triggiani, M;Schwaab, J;Jawhar, M;Caroppo, F;Fortina, AB;Brockow, K;Zink, A;Fuchs, D;Kilbertus, A;Yavuz, AS;Doubek, M;Mattsson, M;Hagglund, H;Panse, J;Sabato, V;Aberer, E;Niederwieser, D;Breynaert, C;Varkonyi, J;Kennedy, V;Lortholary, O;Jakob, T;Hermine, O;Rossignol, J;Arock, ...
    D1
    LEUKEMIA
    2020.
    DOI:10.1038/s41375-019-0632-4 (Copy DOI)
    15.
    Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
    Weisel, K;Spencer, A;Lentzsch, S;Avet-Loiseau, H;Mark, TM;Spicka, I;Masszi, T;Lauri, B;Levin, MD;Bosi, A;Hungria, V;Cavo, M;Lee, JJ;Nooka, A;Quach, H;Munder, M;Lee, C;Barreto, W;Corradini, P;Min, CK;Chanan-Khan, AA;Horvath, N;Capra, M;Beksac, M;Ovilla, R;Jo, JC;Shin, HJ;Sonneveld, P;Casneuf, T;DeAngelis, N;Amin, H;Ukropec, J;Kobos, R;Mateos, MV
    D1
    JOURNAL OF HEMATOLOGY & ONCOLOGY
    2020.
    DOI:10.1186/s13045-020-00948-5 (Copy DOI)
    16.
    Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms
    Baranyai, Z;Biri-Kovács, B;Krátky, M;Szeder, B;Debreczeni, ML;Budai, J;Kovács, B;Horváth, L;Pári, E;Németh, Z;Cervenak, L;Zsila, F;Mehes, E;Kiss, É;Vinsová, J;Bosze, S
    D1
    JOURNAL OF MEDICINAL CHEMISTRY
    2021.
    DOI:10.1021/acs.jmedchem.0c01399 (Copy DOI)
    17.
    Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
    Kajdácsi, E;Jandrasics, Z;Veszeli, N;Makó, V;Koncz, A;Gulyás, D;Köhalmi, KV;Temesszentandrási, G;Cervenak, L;Gál, P;Dobó, J;de Maat, S;Maas, C;Farkas, H;Varga, L
    Q1
    FRONTIERS IN IMMUNOLOGY
    2020.
    DOI:10.3389/fimmu.2020.00794 (Copy DOI)
    18.
    Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms
    Giaccherini, M;Macauda, A;Sgherza, N;Sainz, J;Gemignani, F;Maldonado, JMS;Jurado, M;Tavano, F;Mazur, G;Jerez, A;Góra-Tybor, J;Golos, A;Mohedo, FH;Lopez, JM;Várkonyi, J;Spadano, R;Butrym, A;Canzian, F;Campa, D
    D1
    BLOOD CANCER JOURNAL
    2020.
    DOI:10.1038/s41408-020-00356-5 (Copy DOI)
    19.
    Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus
    Pulanic, D;Batorova, A;Bodo, I;Cervinek, L;Ionita, I;Lissitchkov, T;Melikyan, A;Podolak-Dawidziak, M
    Q1
    ANNALS OF HEMATOLOGY
    2023.
    DOI:10.1007/s00277-023-05114-8 (Copy DOI)
    20.
    The Importance of Complement Testing in Acquired Angioedema Related to Angiotensin-Converting Enzyme Inhibitors
    Balla, Z;Zsilinszky, Z;Pólai, Z;Andrási, N;Kohalmi, KV;Csuka, D;Varga, L;Farkas, H
    Q1
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
    2021.
    DOI:10.1016/j.jaip.2020.08.052 (Copy DOI)
    21.
    Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
    Henry, BM;Sinkovits, G;Szergyuk, I;de Oliveira, MHS;Lippi, G;Benoit, JL;Favaloro, EJ;Pode-Shakked, N;Benoit, SW;Cooper, DS;Muller, V;Ivanyi, Z;Gal, J;Reti, M;Gopcsa, L;Remenyi, P;Szathmary, B;Lakatos, B;Szlavik, J;Bobek, I;Prohaszka, ZZ;Forhecz, Z;Csuka, D;Hurler, L;Kajdacsi, E;Cervenak, L;Mezo, B;Kiszel, P;Masszi, T;Valyi-Nagy, I;Prohaszka, Z
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.796109 (Copy DOI)
    22.
    Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma
    Nagy, A;Bátai, B;Balogh, A;Illés, S;Mikala, G;Nagy, N;Kiss, L;Kotmayer, L;Matolcsy, A;Alpár, D;Masszi, T;Masszi, A;Bödör, C
    Q2
    GENES
    2020.
    DOI:10.3390/genes11070785 (Copy DOI)
    23.
    Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor
    Loules, G;Parsopoulou, F;Zamanakou, M;Csuka, D;Bova, M;González-Quevedo, T;Psarros, F;Porebski, G;Speletas, M;Firinu, D;del Giacco, S;Suffritti, C;Makris, M;Vatsiou, S;Zanichelli, A;Farkas, H;Germenis, AE
    JOURNAL OF CLINICAL MEDICINE
    2020.
    DOI:10.3390/jcm9113402 (Copy DOI)
    24.
    Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
    Lin, WY;Fordham, SE;Hungate, E;Sunter, NJ;Elstob, C;Xu, YB;Park, C;Quante, A;Strauch, K;Gieger, C;Skol, A;Rahman, T;Sucheston-Campbell, L;Wang, JK;Hahn, T;Clay-Gilmour, AI;Jones, GL;Marr, HJ;Jackson, GH;Menne, T;Collin, M;Ivey, A;Hills, RK;Burnett, AK;Russell, NH;Fitzgibbon, J;Larson, RA;Le Beau, MM;Stock, W;Heidenreich, O;Alharbi, A;Allsup, DJ;Houlston, RS;Norden, J;Dickinson, AM;Douglas, E;Lendrem, C;Daly, AK;Palm, L;Piechocki, K;Jeffries, S;Bornhäuser, M;Röllig, C;Altmann, H;Ruhnke, L;Kunad...
    D1
    NATURE COMMUNICATIONS
    2021.
    DOI:10.1038/s41467-021-26551-x (Copy DOI)
    25.
    Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors
    Szabó, Z;Szabó, T;Bodó, K;Kemenesi, G;Földes, F;Kristóf, K;Barabás, E;Vásárhelyi, B;Prohászka, Z;Fodor, E;Jakab, F;Berki, T;Lacza, Z
    Q3
    PRACTICAL LABORATORY MEDICINE
    2021.
    DOI:10.1016/j.plabm.2021.e00222 (Copy DOI)
    26.
    International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
    Germenis, AE;Margaglione, M;Pesquero, JB;Farkas, H;Cichon, S;Csuka, D;Lera, AL;Rijavec, M;Jolles, S;Szilagyi, A;Trascasa, ML;Veronez, CL;Drouet, C;Zamanakou, M
    Q1
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
    2020.
    DOI:10.1016/j.jaip.2019.10.004 (Copy DOI)
    27.
    Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura
    Pereira, LCV;Roose, E;Graça, NAG;Sinkovits, G;Kangro, K;Joly, BS;Tellier, E;Kaplanski, G;Falter, T;Von Auer, C;Rossmann, H;Feys, HB;Reti, M;Prohaszka, Z;Lämmle, B;Voorberg, J;Coppo, P;Veyradier, A;De Meyer, SF;Männik, A;Vanhoorelbeke, K
    D1
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS
    2021.
    DOI:10.1111/jth.15170 (Copy DOI)
    28.
    Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline The COMPASS MRI Substudy
    Sharma, M;Hart, RG;Smith, EE;Bosch, J;Eikelboom, JW;Connolly, SJ;Dyal, L;Reeh, KW;Casanova, A;Diaz, R;Lopez-Jaramillo, P;Ertl, G;Störk, S;Dagenais, GR;Lonn, EM;Ryden, L;Tonkin, AM;Varigos, JD;Bhatt, DL;Branch, KRH;Probstfield, JL;Kim, JH;O'Donnell, M;Vinereanu, D;Fox, KAA;Liang, Y;Liu, LS;Zhu, J;Pogosova, N;Maggioni, AP;Avezum, A;Piegas, LS;Keltai, K;Keltai, M;Berkowitz, SD;Yusuf, S
    D1
    STROKE
    2020.
    DOI:10.1161/STROKEAHA.120.029762 (Copy DOI)
    29.
    The diagnostic value of rapid anti IgM and IgG detecting tests in the identification of patients with SARS CoV-2 virus infection
    Vásárhelyi, B;Kristóf, K;Ostorházi, E;Szabó, D;Prohászka, Z;Merkely, B
    Q4
    ORVOSI HETILAP
    2020.
    DOI:10.1556/650.2020.31859 (Copy DOI)
    30.
    How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy
    Dohy, Z;Vereckei, A;Horvath, V;Czimbalmos, C;Szabo, L;Toth, A;Suhai, FI;Csecs, I;Becker, D;Merkely, B;Vago, H
    Q3
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY
    2020.
    DOI:10.1111/anec.12763 (Copy DOI)
    31.
    Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children
    Stolbová, S;Bezdícka, M;Prohászka, Z;Csuka, D;Hrachovinová, I;Burkert, J;Simánková, N;Pruhová, S;Zieg, J
    Q1
    EUROPEAN JOURNAL OF PEDIATRICS
    2020.
    DOI:10.1007/s00431-020-03666-9 (Copy DOI)
    32.
    Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
    Delgado, IG;Corvillo, F;Nozal, P;Arjona, E;Madrid, A;Melgosa, M;Bravo, J;Szilágyi, A;Csuka, D;Veszeli, N;Prohászka, Z;Sánchez-Corral, P
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.641656 (Copy DOI)
    33.
    FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
    Garam, N;Cserhalmi, M;Prohászka, Z;Szilágyi, A;Veszeli, N;Szabó, E;Uzonyi, B;Iliás, A;Aigner, C;Schmidt, A;Gaggl, M;Sunder-Plassmann, G;Bajcsi, D;Brunner, J;Dumfarth, A;Cejka, D;Flaschberger, S;Flögelova, H;Haris, A;Hartmann, A;Heilos, A;Mueller, T;Rusai, K;Arbeiter, K;Hofer, J;Jakab, D;Sinkó, M;Szigeti, E;Bereczki, C;Janko, V;Kelen, K;Reusz, GS;Szabó, AJ;Klenk, N;Kóbor, K;Kojc, N;Knechtelsdorfer, M;Laganovic, M;Lungu, AC;Meglic, A;Rus, R;Levart, TK;Macioniene, E;Miglinas, M;Pawlowska, A...
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.720183 (Copy DOI)
    34.
    A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency
    Vatsiou, S;Zamanakou, M;Loules, G;Psarros, F;Parsopoulou, F;Csuka, D;Valerieva, A;Staevska, M;Porebski, G;Obtulowicz, K;Magerl, M;Maurer, M;Speletas, M;Farkas, H;Germenis, AE
    Q1
    ALLERGOLOGY INTERNATIONAL
    2020.
    DOI:10.1016/j.alit.2019.12.009 (Copy DOI)
    35.
    Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation
    Mezö, B;Horvath, O;Sinkovits, G;Veszeli, N;Krivan, G;Prohaszka, Z
    Q1
    FRONTIERS IN MEDICINE
    2020.
    DOI:10.3389/fmed.2020.569291 (Copy DOI)
    36.
    Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
    Levy, DS;Farkas, H;Riedl, MA;Hsu, FI;Brooks, JP;Cicardi, M;Feuersenger, H;Pragst, I;Reshef, A
    Q2
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY
    2020.
    DOI:10.1186/s13223-020-0409-3 (Copy DOI)
    37.
    A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review
    Turudic, D;Milosevic, D;Bilic, K;Prohászka, Z;Bilic, E
    Q1
    JOURNAL OF CLINICAL MEDICINE
    2022.
    DOI:10.3390/jcm11102779 (Copy DOI)
    38.
    Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura
    Kangro, K;Roose, E;Joly, BS;Sinkovits, G;Falter, T;von Auer, C;Rossmann, H;Reti, M;Voorberg, J;Prohászka, Z;Lämmle, B;Coppo, P;Veyradier, A;De Meyer, SF;Männik, A;Vanhoorelbeke, K
    D1
    BLOOD ADVANCES
    2021.
    DOI:10.1182/bloodadvances.2020004172 (Copy DOI)
    39.
    Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
    Harris, S;Abrahamson, MJ;Ceriello, A;Charpentier, G;Evans, M;Lehmann, R;Liebl, A;Linjawi, S;Holt, RIG;Hosszufalusi, N;Rutten, G;Vilsboll, T
    D1
    DRUGS
    2020.
    DOI:10.1007/s40265-019-01245-3 (Copy DOI)
    40.
    Balneotherapy, a Complementary Non-pharmacological Approach for Non-Inflammatory Complaints in Systemic Lupus Erythematosus: A Pilot Study
    Fritsch, K;Nagy, G;Szekanecz, Z;Szucs, G;Kovacs, L;Bender, T
    Q2
    IN VIVO
    2022.
    DOI:10.21873/invivo.13046 (Copy DOI)
    41.
    Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
    Uzonyi, B;Szabó, Z;Trojnár, E;Hyvärinen, S;Uray, K;Nielsen, HH;Erdei, A;Jokiranta, TS;Prohászka, Z;Illes, Z;Józsi, M
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.660382 (Copy DOI)
    42.
    Hereditary angioedema attack: what happens to vasoactive mediators?
    Ferrara, AL;Bova, M;Petraroli, A;Veszeli, N;Galdiero, MR;Braile, M;Marone, G;Cristinziano, L;Marcella, S;Modestino, L;Farkas, H;Loffredo, S
    Q1
    INTERNATIONAL IMMUNOPHARMACOLOGY
    2020.
    DOI:10.1016/j.intimp.2019.106079 (Copy DOI)
    43.
    Human primary endothelial label-free biochip assay reveals unpredicted functions of plasma serine proteases
    Debreczeni, ML;Szekacs, I;Kovacs, B;Saftics, A;Kurunczi, S;Gál, P;Dobó, J;Cervenak, L;Horvath, R
    D1
    SCIENTIFIC REPORTS
    2020.
    DOI:10.1038/s41598-020-60158-4 (Copy DOI)
    44.
    Associations between serum L-arginine and ficolins in the early of acute ischemic stroke - A pilot study
    Molnar, T;Csuka, D;Pusch, G;Nagy, L;Garred, P;Illes, Z
    Q1
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
    2020.
    DOI:10.1016/j.jstrokecerebrovasdis.2020.104951 (Copy DOI)
    45.
    Primary refractory multiple myeloma: a real-world experience with 85 cases
    Jurczyszyn, A;Waszczuk-Gajda, A;Castillo, JJ;Krawczyk, K;Stork, M;Pour, L;Usnarska-Zubkiewicz, L;Potoczek, S;Hus, I;Valls, JD;Hari, P;Chhabra, S;Gentile, M;Mikala, G;Varga, G;Chim, CS;Fiala, M;Vij, R;Schutz, N;Rodzaj, M;Porowska, A;Vesole, DH;Druzd-Sitek, A;Walewski, J;Nooka, AK
    Q2
    LEUKEMIA & LYMPHOMA
    2020.
    DOI:10.1080/10428194.2020.1788014 (Copy DOI)
    46.
    Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?
    Macauda, A;Giaccherini, M;Sainz, J;Gemignani, F;Sgherza, N;Sánchez-Maldonado, JM;Gora-Tybor, J;Martinez-Lopez, J;Carreño-Tarragona, G;Jerez, A;Spadano, R;Golos, A;Jurado, M;Hernández-Mohedo, F;Mazur, G;Tavano, F;Butrym, A;Várkonyi, J;Canzian, F;Campa, D
    Q1
    INTERNATIONAL JOURNAL OF CANCER
    2021.
    DOI:10.1002/ijc.33337 (Copy DOI)
    47.
    Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy
    Pusztai, A;Hamar, A;Horváth, A;Gulyás, K;Végh, E;Bodnár, N;Kerekes, G;Czókolyová, M;Szamosi, S;Bodoki, L;Hodosi, K;Domján, A;Nagy, G;Szöllosi, I;Lopez, LR;Matsuura, E;Prohászka, Z;Szántó, S;Nagy, Z;Shoenfeld, Y;Szekanecz, Z;Szucs, G
    Q1
    JOURNAL OF RHEUMATOLOGY
    2021.
    DOI:10.3899/jrheum.200916 (Copy DOI)
    48.
    Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre
    Bazsó, A;Kövesdi, A;Rásonyi, R;Nagy, E;Poór, G;Patócs, A;Kiss, E
    Q2
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    2020.
    49.
    Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
    Garam, N;Prohászka, Z;Szilágyi, A;Aigner, C;Schmidt, A;Gaggl, M;Sunder-Plassmann, G;Bajcsi, D;Brunner, J;Dumfarth, A;Cejka, D;Flaschberger, S;Flögelova, H;Haris, A;Hartmann, A;Heilos, A;Mueller, T;Rusai, K;Arbeiter, K;Hofer, J;Jakab, D;Sinkó, M;Szigeti, E;Bereczki, C;Janko, V;Kelen, K;Reusz, GS;Szabó, AJ;Klenk, N;Kóbor, K;Kojc, N;Knechtelsdorfer, M;Laganovic, M;Lungu, AC;Meglic, A;Rus, R;Kersnik-Levart, T;Macioniene, E;Miglinas, M;Pawlowska, A;Stompór, T;Podracka, L;Rudnicki, M;Mayer, G;R...
    Q1
    CLINICAL KIDNEY JOURNAL
    2020.
    DOI:10.1093/ckj/sfz073 (Copy DOI)
    50.
    Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey
    Farkas, H;Kohalmi, KV;Visy, B;Veszeli, N;Varga, L
    Q1
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
    2020.
    DOI:10.1016/j.jaip.2020.02.043 (Copy DOI)
    51.
    Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema
    Kohalmi, KV;Mezo, B;Veszeli, N;Benedek, S;Fehér, A;Holdonner, A;Jesenak, M;Varga, L;Farkas, H
    Q1
    INTERNATIONAL IMMUNOPHARMACOLOGY
    2020.
    DOI:10.1016/j.intimp.2020.106293 (Copy DOI)
    52.
    Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
    Kajdácsi, E;Veszeli, N;Mezo, B;Jandrasics, Z;Kohalmi, KV;Ferrara, AL;Cervenak, L;Varga, L;Farkas, H
    D1
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    2021.
    DOI:10.1007/s12016-021-08847-4 (Copy DOI)
    53.
    c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma
    Di Bacco, A;Bahlis, NJ;Munshi, NC;Avet-Loiseau, H;Masszi, T;Viterbo, L;Pour, L;Ganly, P;Cavo, M;Langer, C;Kumar, SK;Rajkumar, SV;Keats, JJ;Berg, D;Lin, JH;Li, B;Badola, S;Shen, L;Zhang, JC;Esseltine, DL;Luptakova, K;van de Velde, H;Richardson, PG;Moreau, P
    Q2
    EUROPEAN JOURNAL OF HAEMATOLOGY
    2020.
    DOI:10.1111/ejh.13405 (Copy DOI)
    54.
    Research on the predicting power of the revised Tokuhashi system: how much time can surgery give to patients with short life expectancy?
    Mezei, T;Horváth, A;Pollner, P;Czigléczki, G;Banczerowski, P
    Q1
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
    2020.
    DOI:10.1007/s10147-019-01612-w (Copy DOI)
    55.
    The characteristics of upper airway edema in hereditary and acquired angioedema with C1-inhibitor deficiency
    Balla, Z;Andrási, N;Pólai, Z;Visy, B;Czaller, I;Temesszentandrási, G;Csuka, D;Varga, L;Farkas, H
    Q1
    CLINICAL AND TRANSLATIONAL ALLERGY
    2021.
    DOI:10.1002/clt2.12083 (Copy DOI)
    56.
    Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
    Aigner, C;Gaggl, M;Stemer, G;Eder, M;Bohmig, G;Kain, R;Prohaszka, Z;Garam, N;Csuka, D;Sunder-Plassmann, R;Piggott, LC;Haninger-Vacariu, N;Schmidt, A;Sunder-Plassmann, G
    Q1
    JOURNAL OF NEPHROLOGY
    2022.
    DOI:10.1007/s40620-021-00981-8 (Copy DOI)
    57.
    Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx
    Carden, MA;Gaddh, M;Hoskote, A;Brown, M;Merrill, V;Stowell, SR;Chandrakasan, S;Antun, A;Kudchadkar, R;Kotanchiyev, S;Jaye, DL;Bodó, I
    D1
    BLOOD ADVANCES
    2020.
    DOI:10.1182/bloodadvances.2019001148 (Copy DOI)
    58.
    Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
    Aigner, C;Gaggl, M;Kain, R;Prohászka, Z;Garam, N;Csuka, D;Sunder-Plassmann, R;Piggott, LC;Haninger-Vacariu, N;Schmidt, A;Sunder-Plassmann, G
    JOURNAL OF CLINICAL MEDICINE
    2020.
    DOI:10.3390/jcm9040964 (Copy DOI)
    59.
    Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency
    Andrási, N;Veszeli, N;Holdonner, A;Temesszentandrási, G;Kohalmi, KV;Varga, L;Farkas, H
    Q1
    INTERNATIONAL IMMUNOPHARMACOLOGY
    2020.
    DOI:10.1016/j.intimp.2020.106216 (Copy DOI)
    60.
    Usefulness of a Novel Electrocardiographic Score to Estimate the Pre-Test Probability of Acute Pulmonary Embolism
    Vereckei, A;Simon, A;Szénási, G;Katona, G;Hankó, L;Krix, M;Szoke, VB;Botos, VB;Járai, Z;Masszi, T
    Q1
    AMERICAN JOURNAL OF CARDIOLOGY
    2020.
    DOI:10.1016/j.amjcard.2020.05.042 (Copy DOI)
    61.
    Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema
    Bernstein, JA;Schwartz, L;Yang, W;Baker, J;Anderson, J;Farkas, H;Aygören-Pürsün, E;Bygum, A;Jacobs, I;Feuersenger, H;Pragst, I;Riedl, MA
    Q1
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    2020.
    DOI:10.1016/j.anai.2020.05.015 (Copy DOI)
    62.
    Epidemiology of early infections after autologous hematopoietic stem cell transplantation Analysis of data from 699 patients treated in a Hungarian centre
    Lakatos, B;Szabó, H;Csordás, K;Tatai, G;Nikolova, R;Csomor, J;Reményi, P;Masszi, T;Vályi-Nagy, I;Sinkó, J
    Q4
    ORVOSI HETILAP
    2020.
    DOI:10.1556/650.2020.31638 (Copy DOI)
    63.
    Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
    Haninger-Vacariu, N;Aigner, C;Gaggl, M;Kain, R;Prohászka, Z;Böhmig, GA;Sunder-Plassmann, R;Sunder-Plassmann, G;Schmidt, A
    Q1
    CLINICAL KIDNEY JOURNAL
    2021.
    DOI:10.1093/ckj/sfaa113 (Copy DOI)
    64.
    Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
    Macauda, A;Piredda, C;Clay-Gilmour, A;Sainz, J;Buda, G;Markiewicz, M;Barington, T;Ziv, E;Hildebrandt, MAT;Belachew, AA;Varkonyi, J;Prejzner, W;Druzd-Sitek, A;Spinelli, J;Andersen, NF;Hofmann, JN;Dudzinski, M;Martinez-Lopez, J;Iskierka-Jazdzewska, E;Milne, RL;Mazur, G;Giles, GG;Ebbesen, LH;Rymko, M;Jamroziak, K;Subocz, E;Reis, RM;Garcia-Sanz, R;Suska, A;Haastrup, EK;Zawirska, D;Grzasko, N;Vangsted, AJ;Dumontet, C;Kruszewski, M;Dutka, M;Camp, NJ;Waller, RG;Tomczak, W;Pelosini, M;Razny, M;Marques, ...
    Q1
    INTERNATIONAL JOURNAL OF CANCER
    2021.
    DOI:10.1002/ijc.33547 (Copy DOI)
    65.
    Biological therapy in hereditary angioedema: transformation of a rare disease
    Longhurst, H;Farkas, H
    Q1
    EXPERT OPINION ON BIOLOGICAL THERAPY
    2020.
    DOI:10.1080/14712598.2020.1724280 (Copy DOI)
    66.
    Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
    Melaiu, O;Macauda, A;Sainz, J;Calvetti, D;Facioni, MS;Maccari, G;ter Horst, R;Netea, MG;Li, Y;Grzasko, N;Moreno, V;Jurczyszyn, A;Jerez, A;Watek, M;Varkonyi, J;Garcia-Sanz, R;Kruszewski, M;Dudzinski, M;Kadar, K;Jacobsen, SEH;Mazur, G;Andersen, V;Rybicka, M;Zawirska, D;Razny, M;Zaucha, JM;Ostrovsky, O;Iskierka-Jazdzewska, E;Reis, RM;Stepien, A;Beider, K;Nagler, A;Druzd-Sitek, A;Marques, H;Martinez-Lopez, J;Lesueur, F;Avet-Loiseau, H;Vangsted, AJ;Krawczyk-Kulis, M;Butrym, A;Jamroziak, K;Dumontet, C...
    Q1
    INTERNATIONAL JOURNAL OF CANCER
    2021.
    DOI:10.1002/ijc.33377 (Copy DOI)
    67.
    Repeated spontaneous remission of atypical hemolytic-uremic syndrome caused by influenza – A case report
    Flögelová, H.; Volejníková, J.; Hrachovinová, I.; Prohászka, Z.; Šeda, M.; Gumulec, J.;
    Q4
    CESKO-SLOVENSKA PEDIATRIE / CZECHO-SLOVAK PEDIATRICS 0069-2328 1805-4501
    2020.
    68.
    Long-term (10 year) results of Yttrium-90 radiosynoviorthesis in inflammed knee osteoarthritis A prospective observational study
    Szentesi, M;Nagy, Z;Géher, P;Papp, I;Kampen, WU
    Q4
    ORVOSI HETILAP
    2020.
    DOI:10.1556/650.2020.31728 (Copy DOI)
    69.
    Investigation of TGFB1-1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation
    Kövy, P;Meggyesi, N;Varga, L;Balassa, K;Bors, A;Gopcsa, L;Paksi, M;Bátai, A;Vad, E;Sinkó, J;Tordai, A;Masszi, T;Reményi, P;Andrikovics, H
    Q1
    BONE MARROW TRANSPLANTATION
    2020.
    DOI:10.1038/s41409-019-0656-4 (Copy DOI)
    70.
    Dense deposit disease in an adolescent male mimicking acute post-streptococcal glomerulonephritis
    Siomou, E;Liapis, G;Zisi, A;Csuka, D;Prohászka, Z
    Q4
    HIPPOKRATIA
    2020.
    71.
    A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and after diagnosis - an Eastern European perspective
    Maravic, Z;Rawicka, I;Benedict, A;Wyrwicz, L;Horvath, A;Fotaki, V;Carrato, A;Borras, JM;Ruiz-Casado, A;Petranyi, A;Lemmens, L;Espín-Basany, E;Trenevski, JS
    Q1
    ESMO OPEN
    2020.
    DOI:10.1136/esmoopen-2020-000850 (Copy DOI)
    72.
    Identification of the best-suited donor for generating virus-specific T cells
    Tasnády, S;Karászi, É;Szederjesi, A;Bihari, G;Juhász, Z;Hardi, A;Kriván, G;Kállay, K;Reményi, P;Sinkó, J;Mikala, G;Réti, M;Masszi, T
    Q2
    VOX SANGUINIS
    2020.
    DOI:10.1111/vox.12857 (Copy DOI)
    73.
    A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome-Case Report
    Pollack, S;Eisenstein, I;Mory, A;Paperna, T;Ofir, A;Baris-Feldman, H;Weiss, K;Veszeli, N;Csuka, D;Shemer, R;Glaser, F;Prohaszka, Z;Magen, D
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.608604 (Copy DOI)
    74.
    Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress
    Ariens, R;Becattini, C;Bender, M;Bergmeier, W;Castoldi, E;Devreese, K;Ellis, M;Gailani, D;Ignjatovic, V;James, PD;Kerrigan, S;Lambert, M;Lee, LH;Levi, M;Maugeri, N;Meijers, J;Melero-Martin, J;Michelson, AD;Mingozzi, F;Neeves, K;Ni, HY;Olsson, AK;Prohaszka, Z;Ranson, M;Riva, N;Senis, Y;van Ommen, CH;Vaughan, DE;Weisel, J
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
    2020.
    DOI:10.1002/rth2.12368 (Copy DOI)
    75.
    Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review
    Mezei, T;Hajdu, M;Czigléczki, G;Lotz, G;Kocsis, J;Kulka, J;Horváth, A
    Q2
    BMC CANCER
    2020.
    DOI:10.1186/s12885-020-07114-7 (Copy DOI)
    76.
    Ocular signs and comorbidities in monoclonal gammopathy Analysis of 84 eyes of 42 subjects
    Kitti, K;Klaudia, K;Orsolya, N;Gábor, T;László, SG;Anita, C;Nóra, CC;Achim, L;Zsolt, NZ;Gergely, V;László, G;Gábor, M;Nóra, S
    Q4
    ORVOSI HETILAP
    2021.
    DOI:10.1556/650.2021.32228 (Copy DOI)
    77.
    MAP-2:CD55 chimeric construct effectively modulates complement activation
    González-del-Barrio, L;Pérez-Alós, L;Cyranka, L;Rosbjerg, A;Nagy, S;Prohászka, Z;Garred, P;Bayarri-Olmos, R
    Q1
    FASEB JOURNAL
    2023.
    DOI:10.1096/fj.202300571R (Copy DOI)
    78.
    High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival
    Mezo, B;Reindl-Schwaighofer, R;Eskandary, F;Heinzel, A;Wahrmann, M;Doberer, K;Heilos, A;Bond, G;Kläger, J;Kozakowski, N;Haslacher, H;Oberbauer, R;Viklicky, O;Hrubá, P;Halloran, PF;Rusai, K;Prohászka, Z;Böhmig, GA
    Q2
    TRANSPLANTATION DIRECT
    2020.
    DOI:10.1097/TXD.0000000000000978 (Copy DOI)
    79.
    Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
    Haninger-Vacariu, N;Aigner, C;Kain, R;Prohászka, Z;Gaggl, M;Böhmig, GA;Piggott, LC;Sunder-Plassmann, R;Sunder-Plassmann, G;Schmidt, A
    Q3
    KIDNEY MEDICINE
    2020.
    DOI:10.1016/j.xkme.2019.12.004 (Copy DOI)
    80.
    Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients
    Aigner, C;Böhmig, GA;Eskandary, F;Herkner, H;Prohászka, Z;Csuka, D;Kain, R;Gaggl, M;Sunder-Plassmann, R;Müller-Sacherer, T;Oszwald, A;Fischer, G;Schmidt, A;Sunder-Plassmann, G
    Q2
    EUROPEAN JOURNAL OF INTERNAL MEDICINE
    2020.
    DOI:10.1016/j.ejim.2019.11.007 (Copy DOI)
    81.
    Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
    Zuraw, B;Lumry, WR;Johnston, DT;Aygören-Pürsün, E;Banerji, A;Bernstein, JA;Christiansen, SC;Jacobs, JS;Sitz, KV;Gower, RG;Gagnon, R;Wedner, HJ;Kinaciyan, T;Hakl, R;Hanzliková, J;Anderson, JT;McNeil, DL;Fritz, SB;Yang, WH;Tachdjian, R;Busse, PJ;Craig, TJ;Li, HH;Farkas, H;Best, JM;Clemons, D;Cornpropst, M;Dobo, SM;Iocca, HA;Kargl, D;Nagy, E;Murray, SC;Collis, P;Sheridan, WP;Maurer, M;Riedl, MA
    D1
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    2021.
    DOI:10.1016/j.jaci.2020.10.015 (Copy DOI)
    82.
    "A gyermekkori depresszió rizikótényezői" kutatás - múlt, jelen, jövő
    Kapornai, K.; Baji, I.; Benák, I.; Dochnal, R.; Dósa, E.; Kiss, E.; Merkely, B.; Prohászka, Z.; Szabados, E.; Varga, A.; Vetró, Á.; Kovács, M.;
    Q4
    PSYCHIATRIA HUNGARICA 0237-7896
    2020.
    83.
    A minimális reziduális betegség vizsgálata krónikus limfoid leukémiában
    Takács, Ferenc; Kardos, Ilona; Czeti, Ágnes; Aczél, Dóra; Illés, Sarolta; Balogh, Alexandra; Gaál-Weisinger, Júlia; Szalóki, Gábor; Barna, Gábor;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2020.
    DOI:10.1556/2068.2020.53.1.4 (Copy DOI)
    84.
    A SARS-CoV2-járvány hatása a hazai vérellátásra [Effect of the SARS-CoV2 pandemic on Hungarian blood banking]
    Tordai, Attila; Nagy, Sándor; Baróti-Tóth, Klára; Marton, Imelda; Lázár, Mária; Demeter, Judit; Masszi, Tamás; Matusovits, Andrea;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2020.
    DOI:10.1556/2068.2020.53.2.6 (Copy DOI)
    85.
    HAE-AS, a specific disease activity scale for hereditary angioedema with C1-inhibitor deficiency.
    Joao, Forjaz M; Ayala, A; Caminoa, M; Prior, N; Perez-Fernandez, E; Caballero, T; Farkas, Henriette; , ;
    Q3
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 1018-9068 1698-0808
    2021.
    DOI:10.18176/jiaci.0479 (Copy DOI)
    86.
    Szemészeti tünetek és szemészeti társbetegségek monoklonális gammopathiával járó kórképekben
    Szentmáry, Nóra; Kormányos, Kitti; Tóth, Gábor; Sándor, Gábor László; Németh, Orsolya; Csorba, Anita; Czakó, Cecília; Kovács, Klaudia; Nagy, Zoltán Zsolt; Varga, Gergely; Gopcsa, László; Mikala, Gábor;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2021.
    DOI:10.1556/2068.2021.54.2.4 (Copy DOI)

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 04.02.2025
    (c) Semmelweis University - Central Library